HEALTHCARE DESIGN LEADERSHIP CIC

Company limited by guarantee

Company Registration Number:
14476102 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2024

Period of accounts

Start date: 1 December 2023

End date: 30 November 2024

HEALTHCARE DESIGN LEADERSHIP CIC

Contents of the Financial Statements

for the Period Ended 30 November 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

HEALTHCARE DESIGN LEADERSHIP CIC

Directors' report period ended 30 November 2024

The directors present their report with the financial statements of the company for the period ended 30 November 2024

Principal activities of the company

The principal activity of the company is the provision of training and education services

Additional information

The directors present their report and the financial statements for the period from 1st December 2023 to 30th November 2024. Incorporation - The company was incorporated on 10 November 2022. Small companies provision statement: This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. Approved and authorised by the Board on 15/07/2025. Statement of Directors Responsibilities: Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period. In preparing these financial statements, the directors are required to: select suitable accounting policies and apply them consistently, make judgements and accounting estimates that are reasonable and prudent and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.



Directors

The directors shown below have held office during the whole of the period from
1 December 2023 to 30 November 2024

K J Bradley
R A J Etchell
D J Gibson
A I Handa
N Hobbs


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
15 July 2025

And signed on behalf of the board by:
Name: K J Bradley
Status: Director

HEALTHCARE DESIGN LEADERSHIP CIC

Profit And Loss Account

for the Period Ended 30 November 2024

2024 13 months to 30 November 2023


£

£
Turnover: 0 18,938
Cost of sales: 0 ( 10,302 )
Gross profit(or loss): 0 8,636
Administrative expenses: ( 779 ) ( 7,193 )
Operating profit(or loss): (779) 1,443
Profit(or loss) before tax: (779) 1,443
Tax: 0 ( 274 )
Profit(or loss) for the financial year: (779) 1,169

HEALTHCARE DESIGN LEADERSHIP CIC

Balance sheet

As at 30 November 2024

Notes 2024 13 months to 30 November 2023


£

£
Current assets
Cash at bank and in hand: 2,234 3,192
Total current assets: 2,234 3,192
Creditors: amounts falling due within one year: 3 ( 1,844 ) ( 2,023 )
Net current assets (liabilities): 390 1,169
Total assets less current liabilities: 390 1,169
Total net assets (liabilities): 390 1,169
Members' funds
Profit and loss account: 390 1,169
Total members' funds: 390 1,169

The notes form part of these financial statements

HEALTHCARE DESIGN LEADERSHIP CIC

Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 15 July 2025
and signed on behalf of the board by:

Name: K J Bradley
Status: Director

The notes form part of these financial statements

HEALTHCARE DESIGN LEADERSHIP CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

    Other accounting policies

    1. General information: The company is a company limited by guarantee, incorporated in England and Wales, and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation. The address of its registered office is: St Piran House Truro Technology Park Heron Way, Newham Truro Cornwall TR1 2XN England 2. Accounting policies: Summary of significant accounting policies and key accounting estimates. The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated. Statement of compliance: These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. Basis of preparation: These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. Revenue recognition: Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities. Tax: Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income. The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income. Financial instruments: Classification The company holds the following financial instruments: Short term trade and other debtors and creditors, Cash and bank balances. All financial instruments are classified as basic. Recognition and measurement: The company has chosen to apply the recognition and measurement principles in FRS102. Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled. Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments. Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method. 3. Staff numbers: The average number of persons employed by the company (including directors) during the period, was 5.

HEALTHCARE DESIGN LEADERSHIP CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 2. Employees

    2024 13 months to 30 November 2023
    Average number of employees during the period 5 5

HEALTHCARE DESIGN LEADERSHIP CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

3. Creditors: amounts falling due within one year note

2024 13 months to 30 November 2023
£ £
Bank loans and overdrafts 969 969
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 45 30
Taxation and social security 274
Other creditors 830 750
Total 1,844 2,023

COMMUNITY INTEREST ANNUAL REPORT

HEALTHCARE DESIGN LEADERSHIP CIC

Company Number: 14476102 (England and Wales)

Year Ending: 30 November 2024

Company activities and impact

In the financial year from 2023/2024 Healthcare Design Leadership has not delivered any on-site or virtual training as a result of financial pressures within the NHS to fund courses.

Consultation with stakeholders

The HDL partnership continues to consist of a multi-disciplinary faculty of clinicians, healthcare planners, architects, contractors, engineers and researchers, from across the healthcare built environment. When training is delivered it is provided in partnership with NHS teams, from across the healthcare facility from doctors, nurses, physiotherapists and estates professionals. Whilst we ordinarily receive feedback, as no courses were delivered in this period, we have not received any feedback.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
15 July 2025

And signed on behalf of the board by:
Name: K J Bradley
Status: Director